Xgeva 120 MG/1.7 ML vial 1.7ML
Ended Awarded
- Contract number
- SPE2DR26FT901
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $19,877
Award facts
- Contract value 100% obligated
- $19,877.40 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $19,877.40 for XGEVA 120 mg/1.7 ml vials on November 14, 2025, with completion scheduled for November 17, 2025. This is a firm fixed price, non-set-aside contract with performance at AmerisourceBergen's Conshohocken, Pennsylvania location. The delivery order is issued under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. This prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that serves as a critical vendor for federal medical procurement, particularly for military and veteran healthcare systems. The company has demonstrated capability to meet federal procurement requirements through open competition, with its federal contract portfolio encompassing specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains. The DLA Troop Support Medical contract allows AmerisourceBergen to serve customers including the Defense Health Agency and U.S. Coast Guard, supporting the agency's mission to provide essential pharmaceutical commodities to military healthcare programs globally.
Quick answers
Who was awarded contract SPE2DR26FT901?
SPE2DR26FT901 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 14, 2025.
How much is contract SPE2DR26FT901 worth?
The government has obligated $19,877 on SPE2DR26FT901.
Is contract SPE2DR26FT901 an order under another contract?
Yes. SPE2DR26FT901 is a delivery order under SPE2DR25D1053, an indefinite delivery contract.
Was contract SPE2DR26FT901 competed?
The extent of competition for SPE2DR26FT901 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award